These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31802954)

  • 1. Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy.
    Shrestha R; Kharel Sitaula R; Karki P; Joshi SN; Rawal S
    Int Med Case Rep J; 2019; 12():329-333. PubMed ID: 31802954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
    Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
    Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tremendous result of bevacizumab in malignant hypertensive retinopathy.
    Al-Halafi AM
    Oman J Ophthalmol; 2015; 8(1):61-3. PubMed ID: 25709280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravitreal bevacizumab (Avastin(®)) therapy in malignant hypertensive retinopathy: a report of two cases.
    Kim EY; Lew HM; Song JH
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):318-22. PubMed ID: 22149905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema.
    Vyas S; Thapa R; Bajimaya S; Pradhan E; Paudyal G
    Nepal J Ophthalmol; 2016 Jan; 8(15):54-61. PubMed ID: 28242886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Nourinia R; Ahmadieh H; Nekoei E; Malekifar P; Tofighi Z
    Retina; 2018 May; 38(5):970-975. PubMed ID: 28426622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema.
    Warid Al-Laftah FA; Elshafie M; Alhashimi M; Pai A; Farouq M
    Saudi J Ophthalmol; 2010 Oct; 24(4):133-8. PubMed ID: 23960890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
    Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
    Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Intravitreal Ranibizumab Resistant Radiation Retinopathy with Intravitreal Dexamethasone Implant: A Case Report.
    Sabaner MC; Dogan M
    Beyoglu Eye J; 2022; 7(4):324-328. PubMed ID: 36628082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report.
    Sharma A; Madhusudhan RJ; Nadahalli V; Damgude SA; Sundaramoorthy SK
    Indian J Ophthalmol; 2012; 60(3):234-5. PubMed ID: 22569393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema.
    de Andrade FL; Lopes FS; de Andrade GC; Prata TS; Maia A
    Med Hypothesis Discov Innov Ophthalmol; 2016; 5(1):4-9. PubMed ID: 28289686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.